ARTICLE | Clinical News
LB03002 meets growth hormone deficiency endpoint
June 12, 2009 1:15 AM UTC
Bioton S.A. (Warsaw, Poland) and LG Life Sciences Ltd. (KSE:068870) said a double-blind, European and U.S. Phase III trial in 152 adults with growth hormone deficiency showed that subcutaneous LB03002...